Search

Your search keyword '"Verzenio (Medication)"' showing total 9 results
Start Over Descriptor "Verzenio (Medication)" Publisher newsrx llc
9 results on '"Verzenio (Medication)"'

1. Onco360 Selected for VERZENIO[R] Limited Distribution Pharmacy Network

Subjects
United States. Food and Drug Administration, Eli Lilly and Co., Women's health, Pharmacy, Pharmaceutical industry, Drug approval, Drug wholesalers, Health, Women's issues/gender studies, Verzenio (Medication)
Abstract

2017 NOV 2 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Onco360, the nation's largest independent Oncology Pharmacy, announced that it has been selected to [...]

Published
2017

2. An Application for the Trademark 'VERZENIO CONTINUOUS CARE' Has Been Filed by Eli Lilly

Subjects
Eli Lilly and Co. -- Intellectual property, Verzenio (Medication), Intellectual property, Trademarks, Pharmaceutical industry -- Intellectual property, Editors
Abstract

2019 DEC 24 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has [...]

Published
2019

3. Trademark Application for 'VERZENIO VISION' Filed by Eli Lilly

Subjects
Eli Lilly and Co. -- Intellectual property, Verzenio (Medication), Intellectual property, Trademarks, Pharmaceutical industry -- Intellectual property, Editors
Abstract

2019 OCT 28 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application [...]

Published
2019

4. Lilly announces publication of analyses showing benefit of the addition of Verzenio[R] abemaciclib in multiple subgroups of patients with advanced breast cancer identified as having a more concerning prognosis

Subjects
Eli Lilly and Co., Verzenio (Medication), Prognosis, Pharmaceutical industry
Abstract

2019 JAN 6 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Law Weekly -- Eli Lilly and Company (NYSE: LLY) announced npj Breast Cancer published results from [...]

Published
2019

5. An Application for the Trademark 'VERZENIO' Has Been Filed by Eli Lilly

Subjects
Eli Lilly and Co. -- Intellectual property, Verzenio (Medication), Intellectual property, Trademarks, Pharmaceutical industry -- Intellectual property
Abstract

2017 DEC 31 (NewsRx) -- By a News Reporter-Staff News Editor at Oncology Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application [...]

Published
2017

6. VERZENIOTM abemaciclib Approved for Treatment of Metastatic Breast Cancer, Available for Order at Biologics, Inc

Subjects
Eli Lilly and Co., United States. Food and Drug Administration, Verzenio (Medication), Drug therapy, Diseases, Cancer treatment, Pharmaceutical industry, Drug approval, Breast cancer -- Drug therapy, Cancer metastasis -- Drug therapy
Abstract

2017 OCT 25 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- Biologics, Inc., a McKesson Specialty Health oncology pharmacy services company, has been selected by Eli [...]

Published
2017

7. Lilly Reports Topline Results from Phase 3 JUNIPER Trial Evaluating Verzenio abemaciclib in KRAS-Mutated, Advanced Non-Small Cell Lung Cancer

Subjects
Eli Lilly and Co. -- Product development, Verzenio (Medication), Product development, Pharmaceutical industry -- Product development, Non-small cell lung cancer
Abstract

2017 OCT 23 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- Eli Lilly and Company (NYSE: LLY) announced that its Phase 3 JUNIPER study evaluating [...]

Published
2017

8. Lilly MONARCH 3 Study Published in Journal of Clinical Oncology Demonstrates Benefit of Verzenio abemaciclib Plus NSAI in Advanced Breast Cancer

Subjects
Eli Lilly and Co., European Society for Medical Oncology, Verzenio (Medication), Research, Pharmaceutical industry, Breast cancer -- Research
Abstract

2017 OCT 23 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- Eli Lilly and Company (NYSE: LLY) announced that interim results from the double-blind, placebo-controlled [...]

Published
2017

9. Diplomat Selected to Dispense VERZENIO for Breast Cancer

Subjects
Verzenio (Medication), Diseases, Care and treatment, Development and progression, Cancer treatment, Breast cancer -- Development and progression -- Care and treatment
Abstract

2017 OCT 23 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- Diplomat Pharmacy, Inc. (NYSE: DPLO), is now filling prescriptions for newly approved VERZENIO™ (abemaciclib), [...]

Published
2017

Catalog

Books, media, physical & digital resources
See catalog results